As per our report, the global amniotic membrane market size is estimated to grow at a CAGR of 12.16%, reaching USD 1358.14 million in 2026 from USD 765.17 million in 2021. The Americas hold the largest market share in 2018 due to the benefits associated with amniotic membranes and the advancement of surgical cures. The Asia Pacific to grow at the highest growth rate.
The amniotic membrane is the outer layer that surrounds and protects the embryo. It is also an innermost layer of the placenta and consists of a thick basement layer enclosing the amniotic cavity. It is used as a surgical biomaterial, even replacing the skin in pathological conditions, including plastic surgery and skin wound healing. The amniotic membrane applications include the genitourinary tract, Ophthalmology, brain, skin, neck, head, and other surgical procedures.
At Rambam Health Care Campus, Israeli doctors, Haifa, have recently conducted a successful surgery where a woman’s eyesight has been restored using a placenta membrane transplant.
Awareness regarding the benefits associated with amniotic membranes is the prime factor in fuelling the global amniotic membrane market growth.
Increasing hazardous trauma cases, burn cases, surgical cures, and growing awareness of amniotic membrane products' benefit the most prominent trends driving the amniotic membrane market. In addition, rising numbers of cosmetic surgery cases have also contributed favorably towards increasing the market demand and, subsequently, adopting its services.
The global amniotic membrane market has extensively profited from rapid growth in the geriatric population, the increasing amniotic membrane transplantations, and focused research activities worldwide, which increase awareness about the advantages of amniotic membrane transplants.
The new players entering with considerable investments in the development of the amniotic membrane market are significant parts of the market's growth in the upcoming years. In addition, the growth of the updated technological developments, the growing population, and the rising amniotic membrane transplants support the amniotic membrane market.
Factors such as the cost of the therapy and the absence of experienced and skilled professionals hinder the global amniotic membrane market growth.
Besides, the globally increasing amniotic membrane-based surgeries expected the growth of the amniotic membrane market. The professionals do these surgeries, so the shortage of that skilled surgeons can hamper the regional and global markets. Rising healthcare costs do not affect market growth. The research interest showed by medically advanced communities and institutions into novel regenerative medicines and possibly stem cell applications act as opportunities for the amniotic membrane market.
Market Size Available
2020 to 2026
2021 to 2026
By Product, Application, End-User, and Region
Various Analyses Covered
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities
North America, Europe, Asia Pacific, Latin America, Middle East, and Africa
This research report on the global amniotic membrane market has been segmented and sub-segmented based on the product, application, end-user, and region.
Amniotic Membrane Market - By Product:
Based on product type, the cryopreservation amniotic membranes lead the market and predict to reach USD 1,090.08 million by the end of the forecast period. However, the lyophilized amniotic membranes showcase the highest CAGR of 14.18% from 2021 to 2026. The extract of the amniotic membrane can be used to treat the ophthalmic defects in the corneal epithelia. This innovative product's development was based on the lyophilized human amniotic membrane, which allowed the current application to the optical surface of unlimited quantities of amniotic membrane biological factors.
Amniotic Membrane Market - By Application:
Based on the application, the surgical wounds segment held the most significant market shares in the global market in 2020. The growing interests in surgical cures, increasing cases of hazardous trauma, burns, cosmetic surgery, and upcoming Amniotic Membrane applications are definite plus points towards the market's growth.
Amniotic Membrane Market - By End-User:
Amniotic Membrane Market - By Region:
The Americas currently hold the largest market share, whereas Asia-Pacific to have the most significant growth rate. In particular, the North American region is leading the global amniotic membrane market. The market growth in this region is rising because of some factors like the rise in the number of attempted surgeries, the increase in the biotechnology and the pharmaceutical sector, improved healthcare facilities, and growth in medical device manufacturers.
The Asia Pacific region is growing equivalent to North America. Therefore, the Asia Pacific region market for the amniotic membrane will develop radically. The Asia Pacific market is expected to grow with the rise in the patient population and the augments in health care spending. Europe is also contributing a fair market share in the revenue. Particularly the Indian market exhibits the highest growth rate of 13.60% during the forecast period.
KEY MARKET PLAYERS:
A few of the notable companies leading the global amniotic membrane market profiled in this report are Applied Biologics (United States), Alliqua BioMedical Inc. (United States), Integra Lifesciences (United States), Skye Biologics Inc. (United States), MiMedx (United States), Amniox Medical Inc. (United States), Katena Products Inc. (United States), Human Regenerative Technologies LLC (United States), Amnio Technology LLC (United States) and Osiris Therapeutics Inc. (United States).
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 Cryopreserved Amniotic Membrane
5.1.3 Lyophilization Amniotic Membrane
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2.2 Surgical Wounds
5.2.4 Stem Cell Biology
5.2.5 Regenerative Medicine
5.2.7 Y-o-Y Growth Analysis, By Type
5.2.8 Market Attractiveness Analysis, By Type
5.2.9 Market Share Analysis, By Type
5.3.3 Ambulatory Surgical Centers
5.3.4 Specialized Clinics
5.3.5 Research Centers & Laboratory
5.3.7 Y-o-Y Growth Analysis, By Application
5.3.8 Market Attractiveness Analysis, By Application
5.3.9 Market Share Analysis, By Application
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Product
220.127.116.11 By Application
18.104.22.168 By End-User
6.1.4 Market Attractiveness Analysis
22.214.171.124 By Geographical Area
126.96.36.199 By Product
188.8.131.52 By Application
184.108.40.206 By End-User
6.1.5 Market Share Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By Product
22.214.171.124 By Application
126.96.36.199 By End-User
6.2 North America
6.1.2 United States
6.3.6 South Korea
6.5 Latin America
6.4.5 Rest of Latin America
6.6 Middle East & Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Applied Biologics (US)
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Alliqua BioMedical, Inc (US)
8.3 Integra LifeSciences (US)
8.4 MiMedx (US)
8.5 Amniox Medical, Inc. (Florida)
8.6 Katena Products, Inc. (US)
8.7 Human Regenerative Technologies, LLC (US)
8.8 Amnio Technology LLC (US)
8.9 Osiris Therapeutics, Inc. (US)
8.10 Skye Biologics Inc. (California)
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures